WO2022090369A2 - Système sans fil permettant de déclencher un dispositif médical - Google Patents
Système sans fil permettant de déclencher un dispositif médical Download PDFInfo
- Publication number
- WO2022090369A2 WO2022090369A2 PCT/EP2021/079933 EP2021079933W WO2022090369A2 WO 2022090369 A2 WO2022090369 A2 WO 2022090369A2 EP 2021079933 W EP2021079933 W EP 2021079933W WO 2022090369 A2 WO2022090369 A2 WO 2022090369A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- signal
- patient
- ventilator
- physiological
- nfmi
- Prior art date
Links
- 230000006854 communication Effects 0.000 claims abstract description 90
- 238000004891 communication Methods 0.000 claims abstract description 90
- 238000002567 electromyography Methods 0.000 claims abstract description 45
- 230000005540 biological transmission Effects 0.000 claims abstract description 42
- 230000000241 respiratory effect Effects 0.000 claims abstract description 41
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 30
- 230000006698 induction Effects 0.000 claims abstract description 16
- 238000004458 analytical method Methods 0.000 claims abstract description 12
- 230000003387 muscular Effects 0.000 claims abstract description 7
- 230000008878 coupling Effects 0.000 claims description 34
- 238000010168 coupling process Methods 0.000 claims description 34
- 238000005859 coupling reaction Methods 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 33
- 230000000694 effects Effects 0.000 claims description 25
- 238000009423 ventilation Methods 0.000 claims description 21
- 230000003434 inspiratory effect Effects 0.000 claims description 20
- 230000009471 action Effects 0.000 claims description 17
- 239000007789 gas Substances 0.000 claims description 10
- 230000004044 response Effects 0.000 claims description 10
- 238000004804 winding Methods 0.000 claims description 9
- 210000003205 muscle Anatomy 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 238000012806 monitoring device Methods 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 230000001766 physiological effect Effects 0.000 claims description 6
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 230000001360 synchronised effect Effects 0.000 claims description 4
- 230000003534 oscillatory effect Effects 0.000 claims description 3
- 244000144985 peep Species 0.000 claims description 3
- 230000001902 propagating effect Effects 0.000 claims description 3
- 210000002345 respiratory system Anatomy 0.000 claims description 3
- 230000000875 corresponding effect Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 238000012545 processing Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000003750 conditioning effect Effects 0.000 description 5
- 230000001960 triggered effect Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- QVLMCRFQGHWOPM-ZKWNWVNESA-N N-arachidonoyl vanillylamine Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCC1=CC=C(O)C(OC)=C1 QVLMCRFQGHWOPM-ZKWNWVNESA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000003519 ventilatory effect Effects 0.000 description 3
- 230000036982 action potential Effects 0.000 description 2
- 230000007175 bidirectional communication Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/397—Analysis of electromyograms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B13/00—Transmission systems characterised by the medium used for transmission, not provided for in groups H04B3/00 - H04B11/00
- H04B13/005—Transmission systems in which the medium consists of the human body
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B5/00—Near-field transmission systems, e.g. inductive or capacitive transmission systems
- H04B5/20—Near-field transmission systems, e.g. inductive or capacitive transmission systems characterised by the transmission technique; characterised by the transmission medium
- H04B5/24—Inductive coupling
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B5/00—Near-field transmission systems, e.g. inductive or capacitive transmission systems
- H04B5/20—Near-field transmission systems, e.g. inductive or capacitive transmission systems characterised by the transmission technique; characterised by the transmission medium
- H04B5/24—Inductive coupling
- H04B5/26—Inductive coupling using coils
- H04B5/266—One coil at each side, e.g. with primary and secondary coils
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B5/00—Near-field transmission systems, e.g. inductive or capacitive transmission systems
- H04B5/70—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes
- H04B5/72—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes for local intradevice communication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0051—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes with alarm devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/10—Electroencephalographic signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/50—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/60—Muscle strain, i.e. measured on the user
Definitions
- the present disclosure generally pertains to medical device utilization for patient care and, more particularly, to a wireless system for medical device triggering.
- various physiological sensors are typically coupled to a patient. Some of these sensors provide time-critical data to lifesustaining medical devices. Sensors may be coupled to life-sustaining devices via low-latency physical connection (e.g. , wires). However, improved connections that retain the low-latency of physical connections and present less clutter, less restrictions on patient movement, and are more robust to disruption are desirable.
- low-latency physical connection e.g. , wires
- FIG. 1 illustrates a system for triggering a medical device via a physiological sensor device according to one or more embodiments.
- FIG. 2 illustrates a system for triggering a medical device by a surface electromyography (“sEMG”) module via a near-field magnetic induction (“NFMI”) communications link according to one or more embodiments.
- sEMG surface electromyography
- NFMI near-field magnetic induction
- FIG. 3 illustrates the magnetic field coupling associated with the NFMI communications technology utilized in one or more embodiments.
- FIG. 4 illustrates performance of various placements of a receiver coil relative to a transmitter coil according to one or more embodiments.
- Embodiments provide a low-latency wireless communication link used to trigger a medical device based on physiological sensor data.
- NFMI near-field magnetic induction
- Other implementations and uses are also possible. That is, while the present systems are described with respect to a ventilator, other medical devices (e.g., patient monitors or anesthesia machines) could also be implemented in addition to, or in place of, place of the ventilator.
- NFMI wireless communications Some advantages of the use of NFMI wireless communications are its high interference rejection capability, privacy of the NFMI communications at short distances, and the ability of the transmissions to pass through a patient’s body with little degradation in signal integrity.
- NFMI is a short-range radio technology that is well-suited for low latency data streaming applications
- NFMI has excellent human-body compatibility, which is a function of the radio frequency at which it operates.
- NFMI operates at about 10.6 MHz, at which frequency the human body appears almost transparent. This is in contrast to other higher frequency RF signals, which are absorbed or impeded by the body.
- the communication system includes an electromyography (“EMG”) device including electrodes configured to be attached to a patient and generate electrical signals based on respiratory activity of the patient; wherein the EMG device is configured to generate a respiratory effort waveform based on the electrical signals and analyze the respiratory effort waveform; wherein the EMG device includes a first near-field magnetic induction (“NFMI”) transceiver configured to generate at least one transmission signal derived from the analysis of the patient respiratory effort waveform and transmit the at least one transmission signal on at least one NFMI communication channel; and a ventilator configured to provide breathing assistance to the patient, wherein the ventilator includes a second NFMI transceiver configured to receive the at least one transmission signal from the EMG device and a controller configured to adjust the breathing assistance provided to the patient based on the at least one transmission signal.
- EMG electromyography
- NFMI near-field magnetic induction
- One or more embodiments provide a method of wirelessly communicating with a ventilator to provide breathing assistance to a patient.
- the method includes receiving, by an electromyography (“EMG”) device, electrical signals based on muscular respiratory activity of the patient; generating, by the EMG device, a patient respiratory effort waveform based on the electrical signals; analyzing, by the EMG device, the patient respiratory effort waveform; generating, by the EMG device, at least one near-field magnetic induction (“NFMI”) transmission signal derived from the analysis of the patient respiratory effort waveform; transmitting, by the EMG device, the at least one NFMI transmission signal on at least one NFMI communication channel to the ventilator.
- EMG electromyography
- NFMI near-field magnetic induction
- One or more embodiments provide a system for triggering a medical device.
- the system includes a physiological sensor device configured to sense and transmit a first physiological signal; a medical device configured to receive and process the first physiological signal to determine the presence of a trigger; and a near-field magnetic induction (“NFMI”) communications link coupling the physiological signal from the physiological sensor device to the medical device with a latency of less than 10 milliseconds, wherein upon determination that the first physiological signal contains a first trigger, the medical device performs a first action.
- NFMI near-field magnetic induction
- One or more embodiments provide a method for triggering a medical device.
- the method includes sensing a first physiological signal from a physiological sensor device; wirelessly coupling the physiological signal to a medical device; receiving the physiological signal at the medical device; determining that the first physiological signal contains a first trigger; and performing a first action upon the determining.
- One or more embodiments provide an apparatus for coupling a physiological sensor device to a medical device.
- the apparatus includes a first coil with a first primary winding axis oriented in a first direction; a second coil with a second primary winding axis oriented in a second direction, substantially parallel with the first direction; a driver connected to the first coil, the driver configured to receive a first physiological sensor output signal, amplify the sensor output signal, and energize the first coil with the amplified sensor output signal to create a magnetic field; and a receiver connected to the second coil, the receiver configured to receive a loop current from the second coil when the second coil is proximate the first coil and amplify the current to recover an original sensor output signal.
- EMG electromyography
- one or more embodiments provide an electromyography (“EMG”) device, including: one or more electrodes configured to be attached to a patient and generate electrical signals based on muscular respiratory activity of a patient; one or more processors configured to generate a patient respiratory effort waveform based on the electrical signals and analyze the patient respiratory effort waveform; and a first near-field magnetic induction (“NFMI”) transceiver configured to generate at least one transmission signal derived from the analysis of the patient respiratory effort waveform and transmit the at least one transmission signal on at least one NFMI communication channel to a second NFMI transceiver included in a ventilator.
- EMG electromyography
- One or more embodiments provide a method for wirelessly triggering a therapy device.
- the method includes receiving, by a physiological parametermonitoring device, electrical signals based on physiological activity of the patient; generating, by the physiological parameter-monitoring device, a waveform representing the physiological activity of the patient based on the electrical signals; generating, by the physiological parameter-monitoring device, at least one near-field magnetic induction (“NFMI”) transmission signal derived from the waveform; and wirelessly transmitting, by the physiological parameter-monitoring device, the at least one NFMI transmission signal on at least one NFMI communication channel to a therapy device, wherein the at least one NFMI transmission signal is configured to trigger an action performed by the therapy device corresponding to the physiological activity represented in the waveform.
- NFMI near-field magnetic induction
- any direct electrical connection or coupling without additional intervening elements may also be implemented by an indirect connection or coupling or vice versa, as long as the general purpose of the connection or coupling, for example, to transmit a certain kind of signal or to transmit a certain kind of information, is essentially maintained.
- the general purpose of the connection or coupling for example, to transmit a certain kind of signal or to transmit a certain kind of information, is essentially maintained.
- Features from different embodiments may be combined to form further embodiments.
- variations or modifications described with respect to one of the embodiments may also be applicable to other embodiments unless noted to the contrary.
- spatially relative terms such as “beneath,” “below,” “lower,” “above,” “upper” and the like, may be used herein for ease of description to describe one element or feature’s relationship to another element(s) or feature(s) as illustrated in the figures.
- the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures.
- the apparatus may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein may likewise be interpreted accordingly.
- expressions including ordinal numbers may modify various elements.
- such elements are not limited by the above expressions.
- the above expressions do not limit the sequence and/or importance of the elements.
- the above expressions are used merely for the purpose of distinguishing an element from the other elements.
- a first box and a second box indicate different boxes, although both are boxes.
- a first element could be termed a second element, and similarly, a second element could also be termed a first element without departing from the scope of the present disclosure.
- One or more aspects of the present disclosure may be implemented as a non-transitory computer-readable recording medium having stored thereon a program embodying methods/algorithms for instructing the processor to perform the methods/algorithms.
- a non-transitory computer-readable recording medium may have electronically readable control signals stored thereon, which cooperate (or are capable of cooperating) with a programmable computer system such that the respective methods/algorithms are performed.
- the non-transitory computer-readable recording medium can be, for example, a compact disc, readonly memory (“CD-ROM”), digital video disc (“DVD”), BLU-RAY® disc, a random- access memory (“RAM”), a read-only memory (“ROM”), a programmable read-only memory (“PROM”), an electrically programmable read-only memory (“EPROM”), an electrically erasable, programable read-only memory (“EEPROM”), a FLASH memory, or an electronic memory device.
- CD-ROM compact disc
- DVD digital video disc
- BLU-RAY® disc a random- access memory
- RAM random- access memory
- ROM read-only memory
- PROM programmable read-only memory
- EPROM electrically programmable read-only memory
- EEPROM electrically erasable, programable read-only memory
- FLASH memory or an electronic memory device.
- Each of the elements of the present disclosure may be configured by implementing dedicated hardware or a software program on a memory controlling a processor to perform the functions of any of the components or combinations thereof.
- Any of the components may be implemented as a central processing unit (“CPU”) or other processor reading and executing a software program from a recording medium such as a hard disk or a semiconductor memory device.
- CPU central processing unit
- DSP digital signal processor
- ASIC application-specific integrated circuits
- FPGAs field programmable logic arrays
- PLC programmable logic controller
- processor refers to any of the foregoing structures or any other structure suitable for implementation of the techniques described herein.
- a controller including hardware may also perform one or more of the techniques of this disclosure.
- a controller, including one or more processors may use electrical signals and digital algorithms to perform its receptive, analytic, and control functions, which may further include corrective functions.
- Such hardware, software, and firmware may be implemented within the same device or within separate devices to support the various techniques described in this disclosure.
- a signal processing circuit and/or a signal conditioning circuit may receive one or more signals from one or more components and perform signal conditioning or processing thereon.
- Signal conditioning refers to manipulating a signal in such a way that the signal meets the requirements of a next stage for further processing.
- Signal conditioning may include converting from analog to digital (e.g., via an analog-to-digital converter), amplification, filtering, converting, biasing, range matching, isolation and any other processes required to make a signal suitable for processing after conditioning.
- a signal processing circuit may include an analog-to-digital converter (“ADC”) that converts the analog signal from the one or more sensor elements to a digital signal.
- ADC analog-to-digital converter
- DSP digital signal processor
- FIG. 1 illustrates a system 100 for triggering a medical device via a physiological sensor device according to one or more embodiments. It includes a medical device 102, a physiological sensor device 104 comprising one or more sensors 105, and a low-latency wireless communications link 106 communicatively coupling the physiological sensor device 104 to the medical device 102 via wireless communications transceivers 108 and 110 (e.g., via a communication channel).
- the latency is preferably less than 10 milliseconds (ms) and, more preferably, 5 milliseconds (ms) or less, thereby transmitting time-critical data from the physiological sensor device or data from the medical device across the wireless communications link 106.
- one or more signals generated by the sensor 105 are transmitted via the wireless communications transceiver 108 over wireless communications link 106 to the medical device 102 via wireless communications transceiver 110.
- the sensor 105 may be a physiological sensor.
- the wireless communication link 106 between the medical device 102 and the physiological sensor device 104 is a bi-directional communications link.
- the medical device 102 processes the signal to determine if there is any actionable information in the signal that could be used to trigger the medical device 102 to perform an action, such as generate an alert, initiate a medical assistance function, or to modify one of its operating parameters of a currently administered medical treatment while in progress.
- the sensors 105 may be placed proximate to, on, or inside a patient’s body.
- the sensors 105 may be electrodes that attach to the patient for reading electrical signals generated by or passed through the patient.
- the sensors 105 may be configured to measure vital signs, measure electrical stimulation, measure brain electrical activity such as in the case of a electroencephalogram (“EEG”), measure blood oxygen saturation fraction from absorption of light at different wavelengths as it passes through a finger, measure a CO2 level and/or other gas levels in an exhalation stream using infrared spectroscopy, measure oxygen saturation on the surface of the brain or other regions, measure cardiac output from invasive blood pressure and temperature measurements, measure induced electrical potentials over the cortex of the brain, measure blood oxygen saturation from an optical sensor coupled by fiber to the tip of a catheter, and/or measure blood characteristics using absorption of light.
- EEG electroencephalogram
- the sensors 105 measure a physiological characteristic of a patient and transmit electrical measurement signals over a wired or wireless link to the physiological sensor device 104.
- the physiological sensor device 104 is configured to analyze the sensor data received in the measurement signals in order to monitor or otherwise evaluate a condition of the patient.
- the physiological sensor device 104 may detect a monitored condition of the patient based on the sensor data (e.g., via comparing one or more types of sensor data to one or more thresholds).
- a monitored condition is a condition that requires medical treatment, assistance, or intervention in order to sustain the life of the patient or otherwise assist in sustaining or improving the health of the patient.
- first tier monitored condition may correspond to a first treatment level administered by the medical device 102 and a second tier monitored condition may correspond to a second treatment level administered by the medical device 102 that is enhanced with respect to the first treatment level.
- different operation parameters may be set at the medical device 102 based on the treatment level indicated by the physiological sensor device 104. What constitutes first tier and second tier conditions may be implementation specific, and may depend on factors such as, without limitation, the condition(s) being monitored and the health of the patient.
- the physiological sensor device 104 is configured to generate a one or more communication signals (e.g., a raw sensor data signal, a control signal, an event signal, a flag signal, and/or a trigger signal), and transmit the one or more communication signals via the wireless communications transceiver 108 across the wireless communications link 106 to the wireless communications transceiver 110 of the medical device 102.
- the wireless communications transceivers 108 and 110 are induction coils that are capable of transmitting and receiving NFMI communication signals. This allows for bi-directional communication between the physiological sensor device 104 and the medical device 102.
- the wireless communications transceivers 108 and 110 communicate by coupling a magnetic field between the two devices.
- the magnetic field may be referred to as a non-propagating magnetic field or an evanescent field and the coupling between the two coils may be referred to as an evanescent coupling or a near-field coupling.
- the communications concept involves a transmitter coil in one device modulating a magnetic field that is measured by means of a receiver coil in another device.
- a current passed through the transmitter coil produces a corresponding magnetic field.
- the magnetic field induces a corresponding voltage across the terminals of the receiver coil via inductive or magnetic coupling that can be detected by the receiver.
- a modulated current produces a modulated magnetic field.
- the transceiver that performs a transmission may be referred to as a transmitter comprising the transmitter coil and corresponding transmitter circuitry configured to energize the transmitter coil and modulate the magnetic field that is the communication signal).
- the transceiver performs the receiving may be referred to as a receiver comprising the receiver coil and corresponding receiver circuitry configured to detect the modulated magnetic field via the receiver coil and demodulate or otherwise decode the communication signal.
- the medical device 102 is a medical treatment device that is configured to administer medical treatment to a patient.
- the one or more communication signals from the physiological sensor device 104 is intended to, for example, provide raw sensor data, a control signal, an event signal, a flag signal, and/or a trigger signal to trigger an action, such as a medical assistance function, or a response, including modifying one or more operating parameters corresponding to the medical assistance function, to list a few examples.
- a communication signal may also indicate a treatment level based on the detected condition of the patient.
- a transmitter of the physiological sensor device 104 may be configured to modulate the magnetic field and thereby modulate the communication signals transmitted by the wireless communications transceiver 108 based on the information to be transmitted via the corresponding communication signal.
- the transmitted signal may be modulated by amplitude and/or frequency modulation that is to be decoded by the receiver circuitry at the medical device 102.
- a communication signal may be a trigger signal that triggers a specific function of the medical device 102. In response to detecting the trigger signal, the medical device is configured to perform the triggered function or action.
- Another communication signal may include control information that may include control data, instructions, or data indicating an instruction set corresponding to which functions the medical device 102 is to perform and/or which operating parameters are to be set or adjusted by the medical device 102 for administering treatment to a patient.
- the medical device 102 may transmit, via its wireless communications transceiver 110, an acknowledgement signal to the physiological sensor device 104 indicating that the communication signal was successfully received.
- the acknowledgement signal may indicate that the trigger signal was successfully received and/or that the operating parameters have been set or adjusted according to the received instructions.
- the medical device 102 comprises a ventilator and physiological sensor device 104 comprises a surface electromyography (“sEMG”) sensor module or pod.
- sEMG is a non-invasive procedure involving the detection, recording, and interpretation of the electric activity of groups of muscles at rest and during activity. Electrical measurements for muscles at rest may referred to as “static” and for muscles during activity may be referred to as “dynamic”. The procedure is performed using a single or an array of electrodes placed on the skin surface at different sites and specifically over the muscles to be tested. Electrical activity is assessed by computer analysis of the frequency spectrum, amplitude, or root mean square of the electrical action potential.
- An sEMG pod via the sensors 105 that are attached in proximity to the chest or abdomen of the patient, may act as a trigger or as a controller for a ventilator, attached to that same patient.
- the communication signals will be communicated wirelessly, and meet an over-the-air latency requirement of less than 10 milliseconds.
- the physiological sensor device 104 comprises an sEMG device and the medical device 102 is a ventilator
- the sEMG device within the physiological sensor device 104 may send communication signals to the ventilator to trigger a function or to adjust one of its breathing assistance parameters in response to electrical activity detected around the musculature of the respiratory system of a patient by the sEMG device.
- Such adjustments may be made to one or more of the ventilator operating or control settings including but not limited to assist control (“AC”), tidal volume (“TV”), positive end-expiratory pressure (“PEEP”), synchronized intermittent mandatory ventilation (“SIMV”), airway pressure release ventilation (“APRV”), pressure support (“PS”), bi-level positive airway pressure (“BIPAP”), continuous positive airway pressure (“CPAP”), high frequency oscillatory ventilation (“HFOV”), and fraction of inspired oxygen (“F1O2”).
- the adjustments to these settings may be made in proportion to a patient’s respiratory effort waveform and may be signaled to the ventilator by the sEMG device.
- the sEMG device and the ventilator are configured to perform proportional breathing assistance such as proportional assist ventilation (“PAV”), and, more specifically, neurally adjusted ventilatory assist (“NAVA”) in order to improve patient-ventilator synchrony.
- PAV proportional assist ventilation
- NAVA neurally adjusted ventilatory assist
- the breathing rhythm of the patient who is actively breathing can be assisted by the ventilator such that the breathing rhythm is synchronized with the muscle activity detected by the sEMG device.
- the ventilator is configured to respond to changes in a patient's ventilatory demand and to decrease patient breathing effort while the patient is actively breathing by actively regulating gas pressure, volume, and flow.
- the ventilator does this based on the communication signals received from the sEMG device.
- the sEMG device generates the communication signals based on an analysis it performs on the sensor data it receives from the sensors 105.
- the sEMG device triggers and controls the PAV or NAVA functions and operation settings of the ventilator.
- ventilator pressure, ventilator flow, ventilator volume, inhalation timing, exhalation timing may all be controlled by the sEMG device via communication signals transmitted to the medical device 102 (e.g., the ventilator).
- the sEMG device controls these parameters based on generating a patient’s respiratory effort waveform and analyzing the waveform to determine the occurrence of one or more events or to determine one or more proportional settings corresponding to ventilator pressure, ventilator flow, ventilator volume.
- the sEMG device utilizes the measurement of the patient respiratory effort waveform (e.g., the diaphragmatic EMG signal) to control the gas delivery of the ventilator.
- the patient respiratory effort waveform e.g., the diaphragmatic EMG signal
- pressure is applied during the inspiratory phase, and as the diaphragm relaxes, airway pressure decreases.
- Inspiration ends at a specific percentage of the peak EMG activity.
- the sEMG device may trigger on and cycle off the ventilatory assist. It may also control the inhalation phase duration by triggering an activity starting time of the inhalation phase via an inspiratory ventilation trigger and by triggering an activity stop time of the inhalation phase via an expiratory ventilation trigger.
- the expiratory ventilation trigger also coincides with a starting time of the exhalation phase of the ventilator.
- the activity starting time of the inhalation phase coincides with an activity stop time of the exhalation phase of the ventilator.
- the sEMG device may transmit an event signal to the ventilator on a first transmission channel via the NFMI.
- the event signal includes a plurality of event flags or event indicators, each of which triggers a specific activity or function of the ventilator and/or may trigger an alarm.
- an inspiratory ventilation trigger is an event flag or an event indicator that triggers the ventilator to pump air into the lungs of the patient.
- An expiratory ventilation trigger is an event flag or an event indicator that triggers the ventilator to stop the inspiratory phase and allow the patient to exhale to start the expiratory phase.
- the event flags may be referred to as discrete event flags as they only occur at discrete time instances when a corresponding event is detected by the sEMG.
- the sEMG may also transmit a proportional control signal to the ventilator on a second transmission channel via the NFMI.
- the sEMG device generates the proportional control signal based on the patient’s respiratory effort waveform.
- the proportional control signal is transmitted continuously during ventilator assist to the ventilator (e.g., as a continuous-time signal or analog signal) to provide dynamic, real-time proportional parameter settings, including a proportional ventilator pressure setting, proportional ventilator flow setting, a proportional ventilator volume setting, or any of the other settings noted above that are derived based on the patient’s respiratory effort waveform.
- the sEMG device constantly adjusts the proportional parameter settings in proportion to the patient’s respiratory effort waveform throughout an entire duration of the ventilator assist or only during the inspiratory phase of the ventilator assist.
- the proportional control signal may be triggered and transmitted by the sEMG in response to initializing the inspiratory phase of the ventilator assist, and stopped by the sEMG when the inspiratory phase concludes for a given cycle.
- the ventilator In response to receiving one or more of the proportional parameter settings, the ventilator applies a corresponding gas pressure, gas flow, or gas volume to the patient throughout inspiration and exhalation.
- Such proportional parameter settings may be dynamically adjusted during the inspiratory phase or expiratory phase in real-time as the settings are received from the sEMG device.
- the sEMG device may transmit raw sensor data signal or the patient’s respiratory effort waveform on another transmission channel via the NFMI.
- the raw sensor data may be raw analog data received from the sensors 105 or raw digital data derived therefrom via, for example, an ADC.
- the ventilator may be configured to display the sensor data or the patient’s respiratory effort waveform on a display or perform further analysis for regulating the PAV functions, particularly, for regulating and adjusting the activity starting times, activity stopping times, and the proportional parameter settings.
- the sEMG device is configured to analyze the measurement signals received from the sensors 105 corresponding to the muscular electrical activity and use one or more communication signals to trigger the ventilator to perform an action based on the analysis and/or adjust ventilator parameter settings.
- the sEMG may be configured to transmit sensor data received from the measurement signals via the communication signal, and the ventilator may be configured to analyze the sensor data to determine a corresponding action.
- the signal transmissions are wireless, secure, and fast with low latency.
- FIG. 2 illustrates a system 200 for triggering a ventilator 210 by an sEMG module via a near-field magnetic induction (“NFMI”) communications link using a signal from the sEMG module according to one or more embodiments.
- the system 200 includes an sEMG module 208 and an NFMI ventilator 210.
- the sEMG module 208 includes an sEMG sensor device 218, an NFMI wireless transceiver 214 coupled to an NFMI wireless transceiver coil 202, control electronics 212 (e.g., a “CPU”), and sensors (e.g., physiological sensors such as sensors 105 from FIG. 1 , not illustrated in FIG. 2) that may be placed strategically on a patient for monitoring electrical signals associated with muscular activity.
- a power management unit (“PMU”, not separately shown) manages the power of the sEMG module 208.
- the sEMG sensor device 218 is configured to assess the sensed electrical activity by computer analysis of the frequency spectrum, amplitude, or root mean square of the electrical action potential.
- the NFMI ventilator 210 includes an NFMI wireless transceiver 216 that is coupled to an NFMI wireless transceiver coil 204, control electronics 220 (e.g., a “CPU”), and various tubes, pumps, oxygen tanks, and control electronics related to providing breathing assistance to a patient (not illustrated).
- control electronics 220 e.g., a “CPU”
- various tubes, pumps, oxygen tanks, and control electronics related to providing breathing assistance to a patient not illustrated.
- a power management unit (“PMU”, not separately shown) manages the power of the NFMI ventilator 210.
- sEMG sensor device 218 In operation, electrical activities of a patient’s muscles are detected and analyzed by sEMG sensor device 218.
- the sEMG sensor device 218 determines data to be transmitted and relays the data to a NFMI wireless transceiver 214.
- the NFMI wireless transceiver 214 determines a transmission channel based on the data type and creates a modulated magnetic field via the NFMI wireless transceiver coil 202 to transmit the data on the assigned transmission channel.
- the NFMI wireless transceiver coil 202 is placed within an NFMI communication range of the NFMI wireless transceiver coil 204.
- the sEMG module 208 along with its NFMI wireless transceiver coil 202, may be placed on one lateral side of a patient’s body and the NFMI ventilator 210, along with its NFMI wireless transceiver coil 204, may be placed on an opposite lateral side of a patient’s body.
- This set up allows both the sEMG module 208 and the NFMI ventilator 210 to be attached to the patient without their cables, cords, tubes, and the like becoming entangled with one another.
- the magnetic field generated by one of the transceiver coils is emitted across the patient’s body to the receiving transceiver coil.
- the communication signal can be transmitted through the patient’s body.
- the communication signal can be transmitted through the patient’s body with low latency and can fulfill an over-the- air latency requirement of less than 10 milliseconds, and, more preferably, 5 milliseconds (ms) or less.
- the sEMG module 208 is transmitting signals (e.g., communication data) to the NFMI ventilator 210
- the modulated magnetic field generated by the NFMI wireless transceiver coil 202 is coupled to the NFMI wireless transceiver coil 204, and sensed and processed by the NFMI wireless transceiver 216 to extract the communication data.
- the extracted communication data is further processed by control electronics 220 and is used to trigger an operation and/or an adjustment of the operating parameters of the NFMI ventilator 210.
- breathing assistance may be triggered or initialized by the communication data
- breathing assistance functions may be triggered according to a triggered timing by the communication data
- one or more of the ventilator operating settings or control settings may be adjusted based on the communication data.
- FIG. 3 illustrates the magnetic field coupling associated with the NFMI communications technology utilized in one or more embodiments. It includes a modulated input signal 302 being driven to NFMI wireless transceiver coil 202 (e.g., transmitter coil), a modulated magnetic field 306 associated with the modulated input signal, a coupling 308 (e.g., a wireless link) of the modulated magnetic field 306 into the NFMI wireless transceiver coil 204 (e.g., receiver coil), and the subsequent recovery and output of the received signal 304 that corresponds to the modulated input signal 302.
- NFMI wireless transceiver coil 202 e.g., transmitter coil
- a modulated magnetic field 306 associated with the modulated input signal
- a coupling 308 e.g., a wireless link
- FIG. 4 illustrates performance of various placements of receiving coils relative to a transmitting coil according to one or more embodiments. It includes a transmitting (“TX”) coil 402, a receiving coil A (“RX A”) 404, a receiving coil B (“RX B”) 406, and a receiving coil C (“RX C”) 408.
- the RX A 404 exhibits the best coupling because the area of the TX 402 and the RX A 404 are co-axial.
- the RX B 406 exhibits good coupling since the area of the TX 402 and the RX B 406 are co-planer.
- the RX C 408 exhibits poor coupling due to the area of the RX C 408 being orthogonal to the area of the TX 402.
- communication signals are stronger at greater distances for a co-axial arrangement between coils when compared to a co-planar arrangement, and communication signals are stronger at greater distances for the co-planar arrangement between coils when compared to an orthogonal arrangement.
- the co-axial arrangement is the most sensitive to alignments (or misalignments) between coils given that is has the smallest overlapping area among the three arrangements.
- the co-planar arrangement is the least sensitive to alignments (or misalignments) between coils given that is has the largest overlapping area among the three arrangements.
- a misalignment can have a negative effect on the signal strength of the communication signals. It will be appreciated that any of the coil arrangements may be implemented in the embodiments shown FIGS. 2 and 3 as a matter of design choice.
- At least one of A and B and/or the like generally means A or B or both A and B.
- such terms are intended to be inclusive in a manner similar to the term “comprising”.
- first,” “second,” or the like are not intended to imply a temporal aspect, a spatial aspect, an ordering, etc. Rather, such terms are merely used as identifiers, names, etc. for features, elements, items, etc.
- a first element and a second element generally correspond to element A and element B or two different or two identical elements or the same element.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Computer Networks & Wireless Communication (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Signal Processing (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Primary Health Care (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Un système de communication de ventilateur comprend un dispositif d'électromyographie (« EMG ») comprenant des électrodes d'EMG conçues pour générer des signaux électriques sur la base de l'activité respiratoire musculaire du patient, et un ventilateur. Le dispositif d'EMG est conçu pour générer une forme d'onde d'effort respiratoire du patient sur la base des signaux électriques et analyser la forme d'onde d'effort respiratoire du patient. Le dispositif d'EMG comprend un premier émetteur-récepteur d'induction magnétique en champ proche (« NFMI ») conçu pour générer au moins un signal de transmission dérivé de l'analyse de la forme d'onde d'effort respiratoire du patient et transmettre ledit signal de transmission sur au moins un canal de communication NFMI. Le ventilateur est conçu pour fournir une assistance respiratoire au patient, le ventilateur comprenant un second émetteur-récepteur NFMI conçu pour recevoir ledit signal de transmission en provenance du dispositif d'EMG et un dispositif de commande conçu pour ajuster l'assistance respiratoire fournie au patient sur la base dudit signal de transmission.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21805863.4A EP4236786A2 (fr) | 2020-10-29 | 2021-10-28 | Système sans fil permettant de déclencher un dispositif médical |
CN202180074173.6A CN116437858A (zh) | 2020-10-29 | 2021-10-28 | 用于医疗设备触发的无线系统 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063106932P | 2020-10-29 | 2020-10-29 | |
US63/106,932 | 2020-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2022090369A2 true WO2022090369A2 (fr) | 2022-05-05 |
WO2022090369A3 WO2022090369A3 (fr) | 2022-06-23 |
Family
ID=78592813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/079933 WO2022090369A2 (fr) | 2020-10-29 | 2021-10-28 | Système sans fil permettant de déclencher un dispositif médical |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4236786A2 (fr) |
CN (1) | CN116437858A (fr) |
WO (1) | WO2022090369A2 (fr) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110000489A1 (en) * | 2007-12-20 | 2011-01-06 | Maquet Critical Care Ab | Control unit, method and computer-readable medium for operating a ventilator |
JP5642200B2 (ja) * | 2010-02-01 | 2014-12-17 | ヴェーデクス・アクティーセルスカプ | 無線通信を備える携帯型eegモニタ・システム |
US10667904B2 (en) * | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
EP3624681A4 (fr) * | 2017-05-18 | 2021-03-10 | Advanced Brain Monitoring, Inc. | Systèmes et procédés de détection et de gestion de profils physiologiques |
US11437150B2 (en) * | 2018-05-31 | 2022-09-06 | Inspire Medical Systems, Inc. | System and method for secured sharing of medical data generated by a patient medical device |
WO2019236664A1 (fr) * | 2018-06-06 | 2019-12-12 | Zoll Medical Corporation | Systèmes et procédés de synchronisation de compressions thoraciques avec l'activité myocardique |
EP3653258A1 (fr) * | 2018-11-13 | 2020-05-20 | GTX medical B.V. | Système de commande de neuromodulation en boucle fermée |
CN113631210A (zh) * | 2019-02-22 | 2021-11-09 | 斐雪派克医疗保健有限公司 | 呼吸治疗中的可调节呼气释放 |
-
2021
- 2021-10-28 WO PCT/EP2021/079933 patent/WO2022090369A2/fr unknown
- 2021-10-28 CN CN202180074173.6A patent/CN116437858A/zh active Pending
- 2021-10-28 EP EP21805863.4A patent/EP4236786A2/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022090369A3 (fr) | 2022-06-23 |
CN116437858A (zh) | 2023-07-14 |
EP4236786A2 (fr) | 2023-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7273909B2 (ja) | 特性信号から人間の検出及び識別 | |
EP2478839B1 (fr) | Procédé et appareil pour détecter un effort respiratoire | |
CN109310348B (zh) | 姿势阻塞性睡眠呼吸暂停检测系统 | |
KR102154819B1 (ko) | 수면 스테이지를 결정하는 시스템 및 방법 | |
US9833585B2 (en) | Heart rate coherence using respiratory therapy devices | |
EP3082587B1 (fr) | Système pour valider l'activité inspiratoire des muscles chez un patient et système de ventilation mécanique les utilisant | |
US10137262B2 (en) | Synchronizing mechanical in-exsufflation and diaphragmatic pacing | |
US9949661B2 (en) | Signal processing unit of an EMG measuring system | |
JP2011526196A (ja) | 可拡充式気体伝送システム及び気体伝送方法 | |
AU2011334593A1 (en) | Method and apparatus for detecting cardiac signals | |
US11712574B2 (en) | Accessory-based storage for use with a medical device | |
JP7134507B2 (ja) | 低呼吸モニタリングシステム及び作動方法 | |
US9211384B2 (en) | Respirator or anesthesia system | |
KR102105887B1 (ko) | 폐 내부 공기 부피 변화 및 기도의 폐쇄 정도를 측정하는 비침습적 기계환기 시스템 및 그 동작 방법 | |
US11179099B2 (en) | Reverse dual positive airway pressure challenges for breathing disorder diagnostics | |
CN107126609A (zh) | 基于神经活动调控的睡眠呼吸机呼/吸正压调整方法 | |
US20220362553A1 (en) | Device and method for determining sleep apnoea | |
EP3402389B1 (fr) | Système de surveillance de qualité du sommeil et d'index d'apnées et d'hypopnées | |
EP4236786A2 (fr) | Système sans fil permettant de déclencher un dispositif médical | |
KR102219692B1 (ko) | 저호흡 모니터링 시스템 및 방법 | |
US20170128014A1 (en) | Implantable devices and methods for monitoring copd in patients | |
EP3811863A1 (fr) | Utilisation de la modulation d'amplitude (ma) de signal d'électrocardiogramme (ecg) enregistré par un implant pour surveiller la respiration | |
Gu et al. | Paced breathing and respiratory movement responses evoked by bidirectional constant current stimulation in anesthetized rabbits | |
US20240211566A1 (en) | Systems and methods for digit-based diagnostic chain of custody management | |
US20240211719A1 (en) | Systems and methods for tag-based diagnostic chain of custody management |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21805863 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021805863 Country of ref document: EP Effective date: 20230530 |